YahooOctober 26, 2026 at 9:00 AM NYYesterday
Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment
For many people with cancer, completing treatment can bring a new uncertainty: Is my cancer really gone?
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
